Jeffrey B Landau - Net Worth and Insider Trading
Jeffrey B Landau Net Worth
The estimated net worth of Jeffrey B Landau is at least $126,736 dollars as of 2024-11-05. Jeffrey B Landau is the Chief Business Officer of CytomX Therapeutics Inc and owns about 126,736 shares of CytomX Therapeutics Inc (CTMX) stock worth over $126,736. Details can be seen in Jeffrey B Landau's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey B Landau has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey B Landau
Jeffrey B Landau Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey B Landau owns 1 companies in total, including CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Jeffrey B Landau’s form 4 insider trades.
Insider Ownership Summary of Jeffrey B Landau
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | Chief Financial Officer |
Jeffrey B Landau Latest Holdings Summary
Jeffrey B Landau currently owns a total of 1 stock. Jeffrey B Landau owns 126,736 shares of CytomX Therapeutics Inc (CTMX) as of August 20, 2024, with a value of $126,736.
Latest Holdings of Jeffrey B Landau
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2024-08-20 | 126,736 | 1.00 | 126,736 |
Holding Weightings of Jeffrey B Landau
Jeffrey B Landau Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey B Landau has made a total of 6 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 4,181 shares on August 20, 2024, which brought Jeffrey B Landau around $5,143.
Insider Trading History of Jeffrey B Landau
- 1
Jeffrey B Landau Trading Performance
Jeffrey B Landau Ownership Network
Ownership Network List of Jeffrey B Landau
Ownership Network Relation of Jeffrey B Landau
Jeffrey B Landau Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Jeffrey B Landau is the Chief Financial Officer of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and General Counsel Lloyd A Rowland .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Jeffrey B Landau made 4 insider transaction in CytomX Therapeutics Inc (CTMX) with a net sale of 18,939. Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Jeffrey B Landau Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey B Landau. You might contact Jeffrey B Landau via mailing address: C/o Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Suite 400, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
